Arrhythmia

Among patients with hyperthyroidism who received catheter ablation for atrial fibrillation, the rate of arrhythmia recurrence was higher compared with their euthyroid counterparts at 1 year, researchers reported.

Although more than 25% of contemporary FDA-approved cancer therapies required cardiovascular warnings, post-marketing issuance of the warnings trailed clinical approval by several years, according to a research letter in JAMA Oncology.

An implantable loop recorder feasibly and acceptably monitored arrythmias among patients taking psychotropic medication, according to results of a cohort study in a research letter published in JAMA Psychiatry.

Direct oral anticoagulants vs. aspirin in patients needing ablation for ventricular tachycardia.

Among patients who underwent left ventricular arrhythmia ablation with a radiofrequency catheter, direct oral anticoagulants were superior to aspirin in preventing cerebrovascular events, according to the results of the STROKE-VT trial.

The FDA ordered additional studies for Lamictal following a review of current research by the agency that demonstrated the potential for an increased risk for arrhythmias in patients with heart disease who are taking Lamictal.

Tracheal intubation-related major adverse events including CV instability in critically ill patients.

The frequency of tracheal intubation-related major adverse events, including cardiovascular instability, was high in a cohort of critically ill patients in the international INTUBE study.

Viloxazine extended-release did not appear associated with risk for cardiac arrhythmias or other electrocardiographic parameters, according to study results published in Journal of Clinical Psychiatry.

Short-term treatment with hydroxychloroquine may not confer a risk for arrhythmia in patients with COVID-19, according to a recent study. It was the top story in cardiology last week.